Chimeric Therapeutics Limited (ASX:CHM)
Australia · Delayed Price · Currency is AUD 0.0020
-0.0005 (-20.00%)
Jan 30, 2026, 1:01 PM AEST
Chimeric Therapeutics Market Cap
Chimeric Therapeutics has a market cap or net worth of 11.05 million as of January 30, 2026. Its market cap has increased by 16.89% in one year.
Market Cap
11.05M
Enterprise Value
5.29M
Revenue
12.68M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.00
Market Cap Chart
Since January 18, 2021, Chimeric Therapeutics's market cap has decreased from 97.50M to 11.05M, a decrease of -88.67%. That is a compound annual growth rate of -35.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 28, 2026 | 11.05M | 34.43% |
| Dec 31, 2025 | 8.22M | -25.46% |
| Dec 31, 2024 | 11.02M | -56.60% |
| Dec 29, 2023 | 25.40M | -27.35% |
| Dec 30, 2022 | 34.97M | -59.93% |
| Dec 31, 2021 | 87.26M | -10.51% |
| Jan 18, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neurotech International | 20.74M |
| Tissue Repair | 19.35M |
| Immuron | 12.04M |
| AdAlta | 11.48M |
| Patrys | 10.22M |
| Bio-Gene Technology | 9.15M |
| Invex Therapeutics | 8.64M |
| Zelira Therapeutics | 8.63M |